Penumbra Inc
PEN: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|?q | LOCK|tzX | LOCK|B@m@$Y< |
Penumbra Earnings: Solid Quarterly Results as Firm Awaits Closure of Boston Acquisition
Penumbra reported third-quarter results that featured double-digit revenue growth across both segments, with thrombectomy up 18% and embolization and access up 11% year over year. Neurovascular sales were up 19% off a small base.
